President and Managing Director

Janice completed both her PhD and Post-Doctoral Fellowship in Molecular Pharmacology, and proceeded to develop her skills at the Director level within global pharma.  In 1992, Janice founded, and was President and Managing Director of her first contract research organization (CRO) before selling the company in 2002.

That same year, and with the same drive and determination that led her former company to become one of Canada's fastest growing enterprises, Janice created Montreal-based ethica Clinical Research Inc., a CRO that conducts ethical clinical research associated with the development of drugs, biologics, medical devices, and natural health products.  ethica is celebrated in becoming the first Canadian entity and the first CRO in the world to become accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) - earning its accreditation in December 2006, and its re-accreditation in 2009.  Veritas IRB, a non-profit division of ethica, remains the only Canadian IRB to be accredited by AAHRPP.  In August 2007, ethica formed a joint venture with India-based Matrix Group to create ethicamatrix CRO Pvt Ltd, thus becoming the first Canadian CRO to expand clinical trial management operations to India.

Janice was nominated by Ernst & Young and the Bank of Montreal for the prestigious Entrepreneur of the Year Awards for the Province of Quebec in 2003, 2004, 2005 and again in 2007, and was among the finalists in 2005 and 2007.  Janice is also congratulated in ranking 65th of Canada's top 100 women entrepreneurs in the 2008 PROFIT W100 ranking of Canada's Top Women Entrepreneurs by PROFIT Magazine.

Janice is a member of the Board of Directors for a number of non-profit organizations and publicly-traded companies, and is an active member of various industry organizations.  [jparente@ethicaclinical.com; ext. 214]